Cargando…
Response: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.)
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Endocrine Society
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091483/ https://www.ncbi.nlm.nih.gov/pubmed/25031896 http://dx.doi.org/10.3803/EnM.2014.29.2.208 |
| _version_ | 1782480771287613440 |
|---|---|
| author | Jeon, Eon Ju Jung, Eui Dal |
| author_facet | Jeon, Eon Ju Jung, Eui Dal |
| author_sort | Jeon, Eon Ju |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4091483 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Korean Endocrine Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40914832014-07-16 Response: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.) Jeon, Eon Ju Jung, Eui Dal Endocrinol Metab (Seoul) Response Korean Endocrine Society 2014-06 2014-06-26 /pmc/articles/PMC4091483/ /pubmed/25031896 http://dx.doi.org/10.3803/EnM.2014.29.2.208 Text en Copyright © 2014 Korean Endocrine Society http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Response Jeon, Eon Ju Jung, Eui Dal Response: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.) |
| title | Response: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.) |
| title_full | Response: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.) |
| title_fullStr | Response: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.) |
| title_full_unstemmed | Response: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.) |
| title_short | Response: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.) |
| title_sort | response: diagnostic whole-body scan may not be necessary for intermediate-risk patients with differentiated thyroid cancer after low-dose (30 mci) radioactive iodide ablation (endocrinol metab 2014;29:33-9, eon ju jeon et al.) |
| topic | Response |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091483/ https://www.ncbi.nlm.nih.gov/pubmed/25031896 http://dx.doi.org/10.3803/EnM.2014.29.2.208 |
| work_keys_str_mv | AT jeoneonju responsediagnosticwholebodyscanmaynotbenecessaryforintermediateriskpatientswithdifferentiatedthyroidcancerafterlowdose30mciradioactiveiodideablationendocrinolmetab201429339eonjujeonetal AT jungeuidal responsediagnosticwholebodyscanmaynotbenecessaryforintermediateriskpatientswithdifferentiatedthyroidcancerafterlowdose30mciradioactiveiodideablationendocrinolmetab201429339eonjujeonetal |